Free weight-loss visit planner. Bring your questions to your next appointment.

Tablet topic

Compounded Tirzepatide tablets

Questions to take to a clinician when an advertisement mentions tirzepatide in tablet form.

Browse guides
Illustrative Pulse+ Tirzepatide tablets bottle

Compounded medicines are not FDA-approved. The FDA does not review them for safety, effectiveness or quality before marketing. Package images are illustrations. Read the FDA’s guidance.

Check which form was studied

Approval information for an injection applies to that injectable product. A reference to tirzepatide in an advertisement does not establish how a tablet performs. Ask for evidence specific to the proposed tablet and its intended use.

Identify the preparation

Ask for the full product name, the dispensing pharmacy and the prescribing information. If it is compounded, the finished tablet has not been FDA-approved.

Bring your reason for asking

Perhaps you prefer a tablet, worry about needles or need a plan that fits a busy workday. Tell the clinician which concern matters most so you can discuss the full range of suitable options.

Explore other tablets

Illustrative Pulse+ Semaglutide tablets packaging

Tablet

Compounded Semaglutide tablets

Look up the exact tablet and discuss how the product, your other medicines and your schedule fit together.

Learn more
Illustrative Pulse+ Semaglutide oral drops packaging

Oral liquid

Compounded oral semaglutide

A dropper describes the container. Ask what the liquid contains, who prepared it and what evidence supports that formulation.

Learn more

Pulse+ visit planner

Prepare for your visit

Choose what matters to you. Take your questions to a conversation with your clinician.

What would you like to discuss?

Your selections stay in this tab until you close or reload the page.